Peripheral artery disease or peripheral vascular disease refers to the disease that affects legs and is generally a result of narrowing of the arteries. The common symptoms include intermittent claudication (a condition, in which leg pain occurs regularly whilst walking but subsides after taking rest), skin ulcers, cold skin, bluish skin and unhealthy nail and hair growth in the affected leg. EVAR stent grafts, IVC filters, angiography catheters, hemodynamic flow alteration and plague modification devices are generally used for the treatment of various conditions pertaining to narrowing of arteries and veins.
Smoking, hypertension, diabetes mellitus, dyslipidemia and multiple inflammatory indicators like C-reactive protein, fibrinogen, hyper viscosity and hypercoagulable state are the potential risk factors contributing to peripheral vascular diseases. Life style alternatives, proper medications and revascularization methodologies have proven to suppress the effect of these life threatening conditions.
Market value of peripheral vascular devices:
The major driver influencing the hype of peripheral vascular devices is the increasing pervasiveness of venous diseases or CVI (Chronic Venous Insufficiency). Market analysts have forecasted the high rate of market growth with significant Cumulative Average Growth Rate (CAGR) percent. This implicates the tremendous growth rate of medical sector and pharmaceutical sector. The statistical analysis conducted worldwide divulges the regretful death rates caused due to lag in peripheral and cardiac circulation in the body. Although medications formulated have proven to reduce the effects to a certain extent, they don’t assure the quality of life or potentially reduce mortality. Angioplasty, atherectomy, vascular bypass, thrombolysis and thrombectomy are the vascular or endovascular surgeries usually performed, if the medications fail to show consistent improvement rates in the health. Asymptotic patients, casualties above the age of 70 and diabetic patients above the age of 50 are more prone to peripheral artery disease. The increased rate of geriatric population, the growing need for minimally invasive or non-invasive vascular procedures, reduction of post-surgery traumas and enhancement of swift healing processes have apparently driven the hype potential of Peripheral Vascular Devices’ Market. The inappropriate food habits and life style modifications have boosted the market status and have rendered market with a great revenue yield.
Peripheral transluminal angioplasty balloon catheters, aortic stents, peripheral vascular stents, atherectomy devices, chronic total occlusion devices, PTA guide wires, embolic protection devices, synthetic surgical grafts and inferior vena cava filters are the various categories of peripheral vascular device products available in the market. Peripheral vascular stents are more prevalent in the market. Most of these products, concentrate majorly on the minimally invasive methodologies.
The high growth rate of prevalence for diseases and the lack of proper medical attention in developing regions have heavily driven the market of peripheral vascular devices.